Shares in Glaukos (NYSE:GKOS) are rising today after the ophthalmological-focused medical device maker posted fourth quarter and full year 2018 earnings that topped expectations on Wall Street.
The San Clemente, Calif.-based company posted profits of approximately $1.8 million, or 4¢ per share, on sales of approximately $54.1 million for the three months ended December 31, for bottom-line growth of 76.8% while sales grew 29.8% compared with the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business News
The post Glaukos rises on Street-beating Q4, 2018 earnings appeared first on MassDevice.
from MassDevice https://ift.tt/2T5v2Lh
Cap comentari:
Publica un comentari a l'entrada